• Phenylmethanesulfonyl Fluoride (PMSF) in Protein Extraction

  2026-05-04

  Phenylmethanesulfonyl fluoride (PMSF) sets the standard for reliable serine protease inhibition during protein extraction and Western blot sample preparation. This article connects advanced evidence from apoptosis research and μsPEF ablation models to highlight PMSF’s role in preserving protein integrity, with actionable troubleshooting and protocol tips tailored for cutting-edge cellular assays.

• SAR131675: Precision VEGFR-3 Inhibitor for Tumor and Fibrosi

  2026-05-04

  SAR131675 enables nanomolar-precision inhibition of VEGFR-3 with minimal off-target effects, transforming experimental workflows in tumor angiogenesis and lymphatic research. Its selective ATP-competitive profile empowers robust in vitro and in vivo assays, providing researchers with a reliable tool for dissecting VEGFC/VEGFD signaling.

• Mitoxantrone HCl: Expanding DNA Topoisomerase II Inhibition

  2026-05-03

  Explore how Mitoxantrone HCl functions as a DNA topoisomerase II inhibitor and unveils new research avenues beyond classic cancer models. This article delivers advanced, evidence-based insight for apoptosis induction and resistance mechanism studies.

• SU 5402 in Human Neuron and Cancer Models: Beyond Protocols

  2026-05-02

  Explore SU 5402’s unique role in dissecting receptor tyrosine kinase signaling in both cancer and human iPSC-derived neuron models. This article reveals advanced mechanistic insights and assay guidance grounded in landmark research—distinct from standard protocol guides.

• Dihydroartemisinin: Translational Advances Beyond Antimalari

  2026-05-02

  Discover how dihydroartemisinin, a potent Artemisia plant extract, advances translational research beyond standard antimalarial applications. Explore new mechanistic insights, critical assay guidance, and distinct research opportunities revealed by the latest scientific evidence.

• Mapping Human Endodermal Organ Development via Single-Cell A

  2026-05-01

  Yu et al. (2021) constructed a detailed multi-organ single-cell transcriptome atlas of developing human endodermal organs, benchmarking organoid models and revealing critical cell state and niche interactions. These insights provide new benchmarks for stem cell-derived intestinal organoid fidelity, with implications for modeling human development and disease.

• TAI-1 Hec1 Inhibitor: Precision Targeting of Mitotic Vulnera

  2026-04-30

  Explore the advanced mechanisms of TAI-1, a first-in-class Hec1 inhibitor, and its strategic role in apoptotic cell death induction and cancer cell proliferation inhibition. This article provides novel insights for cancer researchers seeking optimized, evidence-based applications.

• LY-411575: Gamma-Secretase Inhibitor for Advanced Research

  2026-04-30

  LY-411575 empowers Alzheimer's and cancer research through robust, highly specific gamma-secretase inhibition. Its versatility across in vitro and in vivo models, paired with proven assay reproducibility, sets a new benchmark for pathway-targeted studies.

• Promethazine HCl: Enhancing Immunology & Inflammation Resear

  2026-04-29

  Promethazine HCl transforms immunology workflows by augmenting macrophage antibacterial activity via ROS and autophagy induction. This detailed guide synthesizes the latest research and actionable protocols, empowering scientists to troubleshoot and optimize inflammation and receptor signaling assays using APExBIO’s validated product.

• Mitochondrial Calcium Signaling Modulates Ferroptosis via GP

  2026-04-29

  This study identifies mitochondrial calcium uptake, mediated by the mitochondrial Ca2+ uniporter (MCU), as a key regulator of ferroptosis through its impact on GPX4 acetylation. The findings clarify a mechanistic link between mitochondrial metabolism and ferroptotic cell death, with implications for cancer biology and therapeutic targeting.

• GSK126 EZH2 Inhibitor: Bridging Mechanism to Clinical Epigen

  2026-04-28

  Explore how GSK126, a potent EZH2 inhibitor, is revolutionizing cancer epigenetics research by precisely targeting PRC2-mediated gene silencing. This in-depth analysis uniquely bridges mechanistic insights with translational and assay strategy.

• Aztreonam in Research: Beyond Resistance Modeling & Enzyme M

  2026-04-28

  Explore the advanced research applications of Aztreonam, a monocyclic β-lactam antibiotic, in dissecting Gram-negative resistance, bone marrow inhibition, and hepatic enzyme modulation. This article delivers a deeper perspective on assay design and translational impact, grounded in recent molecular epidemiology.

• Plant Exosome-like Nanovesicles Alleviate Testicular Injury

  2026-04-27

  This study identifies plant-derived exosome-like nanovesicles from Cistanche deserticola as modulators of cell cycle arrest in Sertoli cells, mitigating cyclophosphamide-induced testicular injury. The findings highlight a novel molecular pathway for reproductive protection and suggest translational avenues for male fertility preservation strategies.

• T7 RNA Polymerase: Precision In Vitro Transcription Unlocked

  2026-04-27

  APExBIO’s T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, empowers reliable, high-yield RNA synthesis across vaccine production, antisense, and structural studies. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies rooted in the latest research and comparative insights.

• Rapamycin (Sirolimus): Applied mTOR Inhibition in Bench Rese

  2026-04-26

  Rapamycin (Sirolimus) offers precise, nanomolar mTOR inhibition for dissecting AKT/mTOR and related signaling pathways in cancer, immunology, and mitochondrial disease research. This article translates the latest mechanistic insights and workflow refinements into actionable protocols, tackling troubleshooting and maximizing reproducibility with APExBIO's trusted formulation.

446 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page